COVID-19 Variant
Novavax to Seek Regulatory Approval After COVID-19 Vaccine Displays 90% Efficacy in US Trial
2021-06-15
COVID-19: Rise in UK Cases Trigger Global Concerns Over “Highly Infectious” Delta Variant
2021-06-14
Vir, GSK’s Antibody Therapy Effective Against COVID-19 Variants, Reduces Hospitalization and Deaths by 85%
2021-03-11